Literature DB >> 35182301

Sfrp4 and the Biology of Cortical Bone.

Ruiying Chen1, Roland Baron1,2, Francesca Gori3.   

Abstract

PURPOSE OF REVIEW: Periosteal apposition and endosteal remodeling regulate cortical bone expansion and thickness, both critical determinants of bone strength. Yet, the cellular characteristics and local or paracrine factors that regulate the periosteum and endosteum remain largely elusive. Here we discuss novel insights in cortical bone growth, expansion, and homeostasis, provided by the study of Secreted Frizzled Receptor Protein 4 (Sfrp4), a decoy receptor for Wnt ligands. RECENT
FINDINGS: SFRP4 loss-of function mutations cause Pyle disease, a rare skeletal disorder characterized by cortical bone thinning and increased fragility fractures despite increased trabecular bone density. On the endosteal surface, Sfrp4-mediated repression of non-canonical Wnt signaling regulates endosteal resorption. On the periosteum, Sfrp4 identifies as a critical functional mediator of periosteal stem cell/progenitor expansion and differentiation. Analysis of signaling pathways regulating skeletal stem cells/progenitors provides an opportunity to advance our understanding of the mechanisms involved in cortical bone biology.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cathepsin K periosteal stem cells; Cortical bone; Periosteum; Pyle disease; Sfrp4; Wnt

Mesh:

Substances:

Year:  2022        PMID: 35182301      PMCID: PMC9098678          DOI: 10.1007/s11914-022-00727-w

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.163


  83 in total

1.  Periosteal stem cells are essential for bone revitalization and repair.

Authors:  X Zhang; A Naik; C Xie; D Reynolds; J Palmer; A Lin; H Awad; R Guldberg; E Schwarz; R O'Keefe
Journal:  J Musculoskelet Neuronal Interact       Date:  2005 Oct-Dec       Impact factor: 2.041

Review 2.  Genetic control of bone formation.

Authors:  Gerard Karsenty; Henry M Kronenberg; Carmine Settembre
Journal:  Annu Rev Cell Dev Biol       Date:  2009       Impact factor: 13.827

3.  A novel homozygous truncating mutation of the SFRP4 gene in Pyle's disease.

Authors:  N Chatron; G Lesca; A Labalme; P A Rollat-Farnier; P Monin; E Pichot; P Edery; D Sanlaville; M Rossi
Journal:  Clin Genet       Date:  2017-01-16       Impact factor: 4.438

Review 4.  Parathyroid hormone: anabolic and catabolic actions on the skeleton.

Authors:  Barbara C Silva; John P Bilezikian
Journal:  Curr Opin Pharmacol       Date:  2015-04-05       Impact factor: 5.547

Review 5.  Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives.

Authors:  Roland Baron; Eric Hesse
Journal:  J Clin Endocrinol Metab       Date:  2012-01-11       Impact factor: 5.958

6.  Wnt3a binds to several sFRPs in the nanomolar range.

Authors:  Danuta Wawrzak; Mourad Métioui; Erik Willems; Marijke Hendrickx; Erwin de Genst; Luc Leyns
Journal:  Biochem Biophys Res Commun       Date:  2007-04-19       Impact factor: 3.575

7.  Differential temporal effects of sclerostin antibody and parathyroid hormone on cancellous and cortical bone and quantitative differences in effects on the osteoblast lineage in young intact rats.

Authors:  Michael S Ominsky; Danielle L Brown; Gwyneth Van; David Cordover; Efrain Pacheco; Emily Frazier; Linda Cherepow; Marnie Higgins-Garn; J Ignacio Aguirre; Thomas J Wronski; Marina Stolina; Lei Zhou; Ian Pyrah; Rogely Waite Boyce
Journal:  Bone       Date:  2015-08-08       Impact factor: 4.398

8.  Osterix marks distinct waves of primitive and definitive stromal progenitors during bone marrow development.

Authors:  Toshihide Mizoguchi; Sandra Pinho; Jalal Ahmed; Yuya Kunisaki; Maher Hanoun; Avital Mendelson; Noriaki Ono; Henry M Kronenberg; Paul S Frenette
Journal:  Dev Cell       Date:  2014-05-12       Impact factor: 12.270

9.  Cortical-Bone Fragility--Insights from sFRP4 Deficiency in Pyle's Disease.

Authors:  Pelin O Simsek Kiper; Hiroaki Saito; Francesca Gori; Andrea Superti-Furga; Roland Baron; Sheila Unger; Eric Hesse; Kei Yamana; Riku Kiviranta; Nicolas Solban; Jeff Liu; Robert Brommage; Koray Boduroglu; Luisa Bonafé; Belinda Campos-Xavier; Esra Dikoglu; Richard Eastell; Fatma Gossiel; Keith Harshman; Gen Nishimura; Katta M Girisha; Brian J Stevenson; Hiroyuki Takita; Carlo Rivolta
Journal:  N Engl J Med       Date:  2016-06-30       Impact factor: 91.245

10.  PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling.

Authors:  Yumie Rhee; Matthew R Allen; Keith Condon; Virginia Lezcano; Ana C Ronda; Carlo Galli; Naomi Olivos; Giovanni Passeri; Charles A O'Brien; Nicoletta Bivi; Lilian I Plotkin; Teresita Bellido
Journal:  J Bone Miner Res       Date:  2011-05       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.